171 related articles for article (PubMed ID: 2239609)
1. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
[TBL] [Abstract][Full Text] [Related]
2. [Prostatic adenocarcinoma: nodal involvement and prognosis of stage D1 patients].
Arai Y; Oishi K; Okada K; Yoshida O; Kihara Y; Okuno H
Hinyokika Kiyo; 1989 Jun; 35(6):981-6. PubMed ID: 2801398
[TBL] [Abstract][Full Text] [Related]
3. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
Elfving P; Lundgren R
Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
5. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of total prostatectomy for prostatic cancer].
Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
[TBL] [Abstract][Full Text] [Related]
8. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
[TBL] [Abstract][Full Text] [Related]
9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
10. Extranodal extension in lymph node-positive prostate cancer.
Cheng L; Pisansky TM; Ramnani DM; Leibovich BC; Cheville JC; Slezak J; Bergstralh EJ; Zincke H; Bostwick DG
Mod Pathol; 2000 Feb; 13(2):113-8. PubMed ID: 10697266
[TBL] [Abstract][Full Text] [Related]
11. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of prostatic cancer].
Shimazaki J; Fuse H; Akimoto S; Akakura K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):212-8. PubMed ID: 3341783
[TBL] [Abstract][Full Text] [Related]
13. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Utz DC
Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
15. [Results of 15 years of radical prostatectomy].
Frohmüller H; Theiss M; Wirth M; Hofmockel G
Urologe A; 1995 May; 34(3):225-30. PubMed ID: 7610518
[TBL] [Abstract][Full Text] [Related]
16. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
17. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.
Cozzarini C; Bolognesi A; Ceresoli GL; Fiorino C; Rossa A; Bertini R; Colombo R; Da Pozzo L; Montorsi F; Roscigno M; Calandrino R; Rigatti P; Villa E
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):674-83. PubMed ID: 15183470
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
19. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Cadeddu JA; Partin AW; Epstein JI; Walsh PC
Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
[TBL] [Abstract][Full Text] [Related]
20. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
